Quantcast

Latest Pseudomonas Stories

2011-01-10 07:00:00

SAN FRANCISCO, Jan. 10, 2011 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today during the JP Morgan 29th Annual Healthcare Conference, announced that it has initiated its Phase 3 clinical trial program with Aeroquin(TM) (MP-376) for the treatment of pulmonary infections in patients with cystic fibrosis (CF). Aeroquin is Mpex's proprietary aerosol formulation of levofloxacin, an antibiotic that has potent activity against key bacterial pathogens in CF including Pseudomonas aeruginosa. The...

2011-01-06 12:48:49

Genetic resistance to antibiotics is not the only trick bacteria use to resist eradication"“ they also have a second defence strategy known as persistence that can kick in. Researchers reporting in the Journal of Medical Microbiology have now demonstrated for the first time that interplay occurs between the two mechanisms to aid bacterial survival. The findings could lead to novel, effective approaches to treat multi-drug resistant (MDR) infections. 'Persister' bacterial cells are...

2010-12-15 15:06:48

Cold plasma jets could be a safe, effective alternative to antibiotics to treat multi-drug resistant infections, says a study published in the January issue of the Journal of Medical Microbiology on 15 December. The team of Russian and German researchers showed that a ten-minute treatment with low-temperature plasma was not only able to kill drug-resistant bacteria causing wound infections in rats but also increased the rate of wound healing. The findings suggest that cold plasmas might be a...

2010-11-19 13:09:59

Joint press release from NWO and TU Delft Researcher Jean-Paul Meijnen has 'trained' bacteria to convert all the main sugars in vegetable, fruit and garden waste efficiently into high-quality environmentally friendly products such as bioplastics. He will be defending his doctoral thesis on this topic, which was carried out in the context of the NWO B-Basic programme, at TU Delft on Monday 22 November 2010. There is considerable interest in bioplastics nowadays. The technical problems...

2010-10-25 01:47:00

VIENNA, Oct. 25 /PRNewswire-FirstCall/ -- Intercell AG (VSE: ICLL) today announced results from a Phase II clinical trial involving the company's investigational nosocomial vaccine candidate (IC43) against infections with the bacterium Pseudomonas aeruginosa, a leading cause of hospital-acquired infections with increasing antibiotic resistance and hence a very high unmet medical need. In the randomized, controlled Phase II clinical trial (33 sites in 8 countries), about 400...

2010-10-21 10:30:00

MONMOUTH JUNCTION, N.J., Oct. 21 /PRNewswire/ --Transave, Inc., today reported positive clinical trial results on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation), an antibiotic that is entering Phase III development for the treatment of chronic lung infections. The results demonstrate significant clinical benefit and complete the company's Phase II program for the treatment of lung infections due to the bacterium, Pseudomonas aeruginosa in cystic fibrosis...

2010-08-12 01:00:00

WOBURN, Mass. and VEDBAEK, Denmark, Aug. 12 /PRNewswire/ -- AdvanDx today announced the launch of its CE-IVD marked GNR Traffic Light(TM) PNA FISH® test in Europe. GNR Traffic Light PNA FISH is the first-ever test capable of simultaneously identifying Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa directly from positive blood cultures in less than 90 minutes. The GNR Traffic Light is the latest addition to AdvanDx's easy-to-use, molecular-based PNA...

2010-08-05 14:16:37

Detailed pictures published today reveal how a new type of experimental antibiotic can kill bacteria that are already resistant to existing treatments [1]. The findings could ultimately help scientists to develop new antibiotics to tackle the bacteria responsible for many hospital and community-acquired infections. Using an imaging technique called x-ray crystallography, a team of researchers from GlaxoSmithKline (GSK) captured a snapshot of the new compound latched on to the enzyme...

2010-06-17 12:22:00

MONMOUTH JUNCTION, N.J., June 17 /PRNewswire/ -- Transave, Inc., today reported interim results from a multi-cycle Phase II open label clinical trial in cystic fibrosis (CF) patients on its lead investigational drug, ARIKACE(TM) (liposomal amikacin for inhalation). The data indicated that ARIKACE, delivered once daily for 28 consecutive days followed by 56 days off-treatment for four cycles demonstrated statistically significant improvement in lung function that was sustained during the...

2010-06-13 08:05:00

Researchers have discovered a new strain of bacteria that can produce non-toxic, comparatively inexpensive "rhamnolipids," and effectively help degrade polycyclic aromatic hydrocarbons, or PAHs "“ environmental pollutants that are one of the most harmful aspects of oil spills. Because of its unique characteristics, this new bacterial strain could be of considerable value in the long-term cleanup of the massive Gulf Coast oil spill, scientists say. More research to further reduce costs...


Latest Pseudomonas Reference Libraries

0_85d9abd5d0844260722ff2e72fcc9f5a
2011-04-25 21:18:54

Pseudomonas aeruginosa is a common bacterium that can cause disease in animals and humans. It can be found in soil, water, skin flora, and most man-made environments throughout the world. It thrives in normal or hypoxic atmospheres; due to this it has colonized many natural and artificial environments. It can infect animals with damaged tissue or people with reduced immunity. Symptoms are generalized inflammation and sepsis. It can be fatal if colonization occurs in critical body organs,...

More Articles (1 articles) »
Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related